K, S., & RJ, A. (2025). Future Directions in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. The Journal of clinical endocrinology and metabolism, 110(Supplement_1), S74. https://doi.org/10.1210/clinem/dgae759
Chicago Style (17th ed.) CitationK, Sarafoglou, and Auchus RJ. "Future Directions in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency." The Journal of Clinical Endocrinology and Metabolism 110, no. Supplement_1 (2025): S74. https://doi.org/10.1210/clinem/dgae759.
MLA (9th ed.) CitationK, Sarafoglou, and Auchus RJ. "Future Directions in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency." The Journal of Clinical Endocrinology and Metabolism, vol. 110, no. Supplement_1, 2025, p. S74, https://doi.org/10.1210/clinem/dgae759.